Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peginesatide dose finding in hemodialysis anemia
NCT00434330Phase 2Completed
- Sponsor
- Affymax, Inc.
- Start
- Dec 2006
- Primary completion
- Apr 2008
- Modality
- Peptides, Polymer-based Nanoparticles
- Countries
- 3
01
Overview
A Phase 2 trial of peginesatide in anemia of chronic kidney disease (CKD-A), sponsored by Affymax, Inc.. Started Dec 2006; status: completed.
02
Drugs
peginesatide
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT00434330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00434330.